Dana Schiefelbein

Systemic Anti-TNFα Treatment Restores Diabetes-Impaired Skin Repair in ob/ob Mice by Inactivation of Macrophages

Itamar Goren, Elke Müller, Dana Schiefelbein et al. · Journal of Investigative Dermatology · 2007 · 148 citations · Full text

Life Sciences, Dermatology, Immunology +12

Akt1 Controls Insulin-Driven VEGF Biosynthesis from Keratinocytes: Implications for Normal and Diabetes-Impaired Skin Repair in Mice

Itamar Goren, Elke Müller, Dana Schiefelbein et al. · Journal of Investigative Dermatology · 2008 · 89 citations · Full text

Life Sciences, Dermatology, Molecular Biology +14

Oncostatin M Expression Is Functionally Connected to Neutrophils in the Early Inflammatory Phase of Skin Repair: Implications for Normal and Diabetes-Impaired Wounds

Itamar Goren, Heiko Kämpfer, Elke Müller et al. · Journal of Investigative Dermatology · 2006 · 61 citations

Life Sciences, Immunology, Pathology +16

Biphasic Regulation of HMG-CoA Reductase Expression and Activity during Wound Healing and Its Functional Role in the Control of Keratinocyte Angiogenic and Proliferative Responses

Dana Schiefelbein, Itamar Goren, Beate Fißlthaler et al. · Journal of Biological Chemistry · 2008 · 29 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Keratinocyte-Derived Vascular Endothelial Growth Factor Biosynthesis Represents a Pleiotropic Side Effect of Peroxisome Proliferator-Activated Receptor-γ Agonist Troglitazone but Not Rosiglitazone and Involves Activation of p38 Mitogen-Activated Protein Kinase: Implications for Diabetes-Impaired Skin Repair

Dana Schiefelbein, Oliver Seitz, Itamar Goren et al. · Molecular Pharmacology · 2008 · 26 citations

Medicine, Dermatology, Pharmacology +17